Navigation Links
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
Date:5/2/2013

38.7 Property, plant and equipment ("PP&E"), net 951.0 955.8 Goodwill 522.8 644.5 Other intangible assets, net 2,657.2 2,388.1 Deferred tax asset 47.3 46.5 Other non-current assets 34.7 31.5 Total assets 7,585.6 7,317.2 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 1,477.2 1,501.5 Other current liabilities 142.5 144.1 Total current liabilities 1,619.7 1,645.6 Non-current liabilities: Convertible bonds 1,100.0 1,100.0 Deferred tax liability 607.3 520.8 Other non-current liabilities 476.5 241.6 Total liabilities 3,803.5 3,508.0 Equity: Common stock of 5p par value; 1,000 million shares authorized; and 562.8 million shares issued and outstanding (2012: 1,000 million shares authorized; and 562.5 million shares issued and outstanding) 55.7 55.7 Additional paid-in capital 3,002.1 2,981.5 Treasury stock: 11.3 million shares (2012: 10.7 million) (341.6) (310.4) Accumulated other comprehensive income 49.1 86.9 Retained earnings 1,016.8 995.5 Total equity 3,782.1 3,809.2 Total liabilities and equity 7,585.6 7,317.2

Unaudited US GAAP results for the three months to March 31, 2013
Consolidated Statements of Income

3 months to March 31, 2013 2012 $M $M Revenues: Product sales 1,116.7 1,106.9 Royalties 38.5 56.3 Other revenues 6.7 8.6 Total revenues 1,161.9 1,171.8 Costs and expenses: Cost of product sales(1) 155.9 158.4 R&D 224.2 220.3 SG&A(1) 438.7 500.0 Goodwill impairment charge 198.9 - Gain on sale of product rights (6.5) (7.2) Reorganization costs 17.5 - Integration and acquisition costs 4.1 5.3 Total operating expenses 1,032.8 876.8 Operating income 129.1 295.0 Interest income 0.7 0.8 Interest expense (9.1) (10.2) Other income, net (1.1) 1.9 Total other expense, net (9.5) (7.5) Income from continuing operations before income taxes and equity in earnings of equity method investees 119.6 287.5 Income taxes (55.2) (50.0) Equity in earnings of equity method investees, net of taxes 0.4 0.9 Net i
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. Nephros Appoints John C. Houghton as President and Chief Executive Officer
4. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
5. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
6. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
7. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
8. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
9. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... Approach to Blood ... Pressure Management, ... in the discovery and development of novel small,molecule therapeutics, announced ... statistically significant,blood pressure reductions in a Phase 2a study in ...
... MDVN ) today announced that data from an ... antagonist, MDV3100, will be presented,in an oral presentation at ... in Chicago., Session title: New Targeted Strategies ... time: Monday, June 2 at 11:30 a.m. Central Time ...
Cached Medicine Technology:Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3
(Date:8/30/2014)... Pittsburgh, PA (PRWEB) August 30, 2014 "I ... beach because of her crutches," said an inventor from Wetumpka, ... the sights and sounds of the shore, I came up ... beach sand." , She created a prototype for the patent-pending ... The accessory enables the individual to use crutches, walkers, or ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has become ... apnea (a medical problem where the airway collapses during sleep ... the rest they need to face their daily challenges. ... million people in the United States alone have sleep apnea. ... of those treated, many cannot tolerate their prescribed medical device ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 One of the ... era is the gluten-free diet. Originally meant for sufferers of ... a catchall for people who are looking to get healthier ... not only is this kind of information erroneous, it also ... problems because of a drastic change in their food ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 The ... Gut Cure program was created by Karen Brimeyer, who wanted ... the world. , This guide is now easy to ... for instant download. In this guide, the author of the ... gut cure. , Daily Gossip writes in its review ...
(Date:8/30/2014)... August 28th, 2014: With the prevalence ... and the toll that takes on the individual as ... education for physical therapists addresses this problem. , In ... others, Hands-On Seminars is offering discounts on their continuing ... styles are available to fit the individual needs of ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2
... ... special section dedicated to prescription sunglasses , ... New Jersey (PRWEB) May 26, 2010 -- With summer quickly ... in selling prescription glasses has been selling prescription sunglasses since ...
... appendicitis, but a patient,s symptoms are inconsistent with the ... or recurrent appendicitis and surgical treatment, according to a ... printed issue of the journal Radiology . ... results in missed appendicitis, with a possible increased risk ...
... medications should spur patient-doctor discussions, agency says, , TUESDAY, ... as Prevacid, Prilosec and Nexium will now carry a ... heightened risk for fractures, the U.S. Food and Drug ... consumers to use this class of medicines, called proton ...
... ... ... Shield of Massachusetts, Inc. (BCBSMA) and Northeast Health Systems Physician Hospital Organization, Inc. (NEPHO) ... marks the first North Shore physician group to adopt BCBSMA’s global payment model that is ...
... patient outcomes, researchers say , TUESDAY, May 25 (HealthDay ... obstructive pulmonary disease (COPD) do better when they receive ... patients who were given antibiotics early in their hospital ... less likely to have to be readmitted to the ...
... ... side-by-side this summer on extensive and collaborative research projects as part of Houghton College’s ... ... the Division of Math and Natural Science will work side-by-side this summer on extensive ...
Cached Medicine News:Health News:GlassesUSA.com Launches Section for Prescription Sunglasses 2Health News:Appendectomy may be best for patients with positive CT exam 2Health News:FDA Warns of Fracture Risk With Popular Heartburn Drugs 2Health News:FDA Warns of Fracture Risk With Popular Heartburn Drugs 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 2Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 4Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 2Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 3Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 2Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 3Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 4Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 5
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: